Pain relief with intravenous ketamine after cesarean sectio
Phase 2
- Conditions
- Health Condition 1: O80- Encounter for full-term uncomplicated delivery
- Registration Number
- CTRI/2022/11/047573
- Lead Sponsor
- Dr Chethana M
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA I to II Patients Female patients.
Aged between 20 to 40years.
Normal liver and renal function test, Coagulation profile.
Undergoing Lower Segment Caesarean Section Surgery.
Exclusion Criteria
Patients with history of allergy to local Anaesthetics.
Patients with history of mental disorders.
Patient Refusal.
Morbid obesity, Coagulopathy and significant cardiovascular respiratory, renal, hepatic or metabolic diseases or CNS disorders.
Patients with hypertensive disorder due to any cause ( PIH)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Degree of post operative pain relief with single dose of intravenous ketamine during cesarean sectionTimepoint: A visual analogue score will be used to record the participants pain score at 1, 2, 6, 12 hours following surgery. Participants will be asked to rate the intensity of their pain in the scale of one (no pain at all) to 10 (very intense and unimaginable pain).
- Secondary Outcome Measures
Name Time Method First rescue analgesia used. <br/ ><br>Total analgesic consumed in first 24hrs <br/ ><br>Hemodynamic parameters for 24 hours post operatively. <br/ ><br>Adverse effects, if any. <br/ ><br>Timepoint: Participants will be monitored for common side effects, such as nausea, vomiting, headache, hallucination, and itching, and the prevalence of such side effects will be recorded at 1,2,6 and 12 hrs following surgery.